Five Prime Therapeutics, Inc. Proceeds from Issuance Initial Public Offering
Five Prime Therapeutics, Inc. reported Proceeds from Issuance Initial Public Offering of $78.69 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2015-08-07
- Five Prime Therapeutics, Inc. proceeds from issuance initial public offering for the quarter ending 2015-06-30 was $0.00.
- Five Prime Therapeutics, Inc. proceeds from issuance initial public offering for the quarter ending 2015-03-31 was $78.69M, a 96.22% increase year-over-year.
- Five Prime Therapeutics, Inc. proceeds from issuance initial public offering for the quarter ending 2014-09-30 was $0.00.
- Five Prime Therapeutics, Inc. proceeds from issuance initial public offering for the quarter ending 2014-06-30 was -$5.00K.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month |
|---|---|---|---|
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $78.69M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $78.69M 10-Q · filed 2015-05-14 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$5.00K derived: sum of 2 quarters · filed 2015-08-07 | $40.10M 10-Q · filed 2014-11-12 |
| 2014-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $40.10M 10-Q · filed 2015-08-07 | |
| 2014-03-31 | $40.10M 10-Q · filed 2015-05-14 | ||
| 2013-09-30 | $64.89M 10-Q · filed 2014-11-12 |